Pegaspargase biosimilar (Gennova Biopharmaceuticals)

培门冬酶生物类似药（Gennova Biopharmaceuticals）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegaspargase biosimilar (Gennova Biopharmaceuticals)

Drug Alias Name培门冬酶生物仿制药（Gennova Biopharmaceuticals）

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Non-recombinant enzyme

Mechanisms of ActionAspartate-ammonia ligase inhibitorsAmidohydrolases stimulantsAsparagine inhibitors

TargetsAspartate-ammonia ligaseAmidohydrolasesAsparagine

Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGennova

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Inactive IndicationsN/A

ATC CodeL01XX24